Chris P. Pescott
Darmstadt, HE, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 10 publications
Cost-effectiveness of cetuximab-containing regimens for squamous cell carcinoma of the head and neck in Italy.
Journal: Future oncology (London, England)
Published: May 19, 2025
Real-world healthcare resource utilization and costs of weekly versus every-2-week cetuximab in metastatic colorectal cancer.
Journal: Journal of comparative effectiveness research
Published: January 27, 2021
Comparative effectiveness of weekly versus every-2-weeks cetuximab in metastatic colorectal cancer in a US-insured population.
Journal: Journal of comparative effectiveness research
Published: October 29, 2020
Cost-effectiveness of FOLFIRI + cetuximab vs FOLFIRI + bevacizumab in the first-line treatment of RAS wild-type metastatic colorectal cancer in Germany: data from the FIRE-3 (AIO KRK-0306) study.
Journal: Journal of medical economics
Published: January 07, 2020
Cost Effectiveness of Avelumab for Metastatic Merkel Cell Carcinoma.
Journal: PharmacoEconomics - open
Published: January 26, 2019
Real-world cost-effectiveness of cetuximab in the third-line treatment of metastatic colorectal cancer based on patient chart review in the Netherlands.
Journal: Health economics review
Published: October 02, 2017
Economic Evaluation of Three Frequently Used Gonadotrophins in Assisted Reproduction Techniques in the Management of Infertility in the Netherlands.
Journal: Applied health economics and health policy
Published: September 02, 2016
Treatments and costs for recurrent and/or metastatic squamous cell carcinoma of the head and neck in the Netherlands.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: December 19, 2014
Real-world cost-effectiveness of cetuximab in locally advanced squamous cell carcinoma of the head and neck.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: January 28, 2014
Cetuximab in locally advanced squamous cell carcinoma of the head and neck: generalizability of EMR 062202-006 trial results.
Journal: European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery
Published: April 30, 2013
Showing 1-10 of 10
Last Updated: 09/26/2026